BRITTANY LABIT-HERNANDEZ: Open Payments
NPI 1255075156 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 31 payments from 9 companies in 2025. Trend: 2023 $537 · 2024 $243 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 5 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $160 |
| Ardelyx, Inc. | 3 | $157 |
| Medtronic, Inc. | 1 | $140 |
| Amgen Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Fresenius USA Marketing, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Vafseo, Kerendia, SYMPLICITY G3, XPHOZAH 30 MG, TAVNEOS, LOKELMA, VELPHORO, IBSRELA.
Industry payments across AZ — which companies pay providers there.
